173 related articles for article (PubMed ID: 37629293)
21. Application of resonance metallic stents for malignant ureteral obstruction.
Kang Q; Jiang F; Yu Y; Shen C; Lv H; Yang B
Minim Invasive Ther Allied Technol; 2018 Dec; 27(6):333-338. PubMed ID: 29475395
[No Abstract] [Full Text] [Related]
22. Risk Factors for Primary Failure of Metallic Ureteral Stents: Experience from a Tertiary Center.
Hsu JS; Huang CY; Liu KL; Chow PM
J Endourol; 2021 Jun; 35(6):912-918. PubMed ID: 29325432
[No Abstract] [Full Text] [Related]
23. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
24. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents.
Chow PM; Chiang IN; Chen CY; Huang KH; Hsu JS; Wang SM; Lee YJ; Yu HJ; Pu YS; Huang CY
PLoS One; 2015; 10(8):e0135566. PubMed ID: 26267140
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of metallic stents for malignant ureteral obstruction.
Goldsmith ZG; Wang AJ; Bañez LL; Lipkin ME; Ferrandino MN; Preminger GM; Inman BA
J Urol; 2012 Sep; 188(3):851-5. PubMed ID: 22819410
[TBL] [Abstract][Full Text] [Related]
26. Tandem ureteral stents in the management of double-J stent dysfunction in gynecological malignancies.
Ozyer U; Dirim A
Diagn Interv Imaging; 2017 Sep; 98(9):601-608. PubMed ID: 28802719
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction.
Matsuura H; Arase S; Hori Y
Support Care Cancer; 2020 Dec; 28(12):5743-5750. PubMed ID: 32206969
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Follow-Up of Yearly Replaced Double Internal Stents for Extrinsic Malignant Ureteral Obstruction.
Savin Z; Herzberg H; Ben-David R; Dekalo S; Mintz I; Marom R; Barghouthy Y; Mano R; Yossepowitch O; Sofer M
J Endourol; 2021 Jan; 35(1):71-76. PubMed ID: 32668988
[No Abstract] [Full Text] [Related]
29. Metallic ureteral stents in malignant ureteral obstruction: clinical factors predicting stent failure.
Chow PM; Hsu JS; Huang CY; Wang SM; Lee YJ; Huang KH; Yu HJ; Pu YS; Liang PC
J Endourol; 2014 Jun; 28(6):729-34. PubMed ID: 24397490
[TBL] [Abstract][Full Text] [Related]
30. Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents.
Yu SH; Ryu JG; Jeong SH; Hwang EC; Jang WS; Hwang IS; Yu HS; Kim SO; Jung SI; Kang TW; Kwon DD; Park K; Hwang JE; Kim GS
Korean J Urol; 2013 May; 54(5):316-21. PubMed ID: 23700497
[TBL] [Abstract][Full Text] [Related]
31. Stents for malignant ureteral obstruction.
Pavlovic K; Lange D; Chew BH
Asian J Urol; 2016 Jul; 3(3):142-149. PubMed ID: 29264182
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for overall survival in malignant ureteral obstruction.
Mason JB; Creswell M; Egan J; Dall C; Sholklapper T; Galloway LA; Orzel J; Lee H; Desale S; Stamatakis L
Can J Urol; 2022 Jun; 29(3):11162-11169. PubMed ID: 35691038
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Double-J Metallic Mesh Ureteral Stents for Malignant Ureteral Obstruction: A Retrospective Study.
Hori T; Makino T; Kawahara T; Urata S; Miyagi T
In Vivo; 2023; 37(2):806-810. PubMed ID: 36881102
[TBL] [Abstract][Full Text] [Related]
34. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents.
Elsamra SE; Leavitt DA; Motato HA; Friedlander JI; Siev M; Keheila M; Hoenig DM; Smith AD; Okeke Z
Int J Urol; 2015 Jul; 22(7):629-36. PubMed ID: 25950837
[TBL] [Abstract][Full Text] [Related]
35. Influence of Single Stent Size and Tandem Stents Subject to Extrinsic Ureteral Obstruction and Stent Occlusion on Stent Failure.
Amitay-Rosen T; Shilo Y; Dror I; Berkowitz B
J Endourol; 2022 Feb; 36(2):236-242. PubMed ID: 34314233
[No Abstract] [Full Text] [Related]
36. Application of resonance metallic stents for ureteral obstruction.
Wang HJ; Lee TY; Luo HL; Chen CH; Shen YC; Chuang YC; Chiang PH
BJU Int; 2011 Aug; 108(3):428-32. PubMed ID: 21062397
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of long-duration stents for ureteral stricture: which one to choose?
Corrales M; Doizi S; Barghouthy Y; Kamkoum H; Somani B; Traxer O
World J Urol; 2021 Sep; 39(9):3197-3205. PubMed ID: 33386951
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
39. Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction.
Yoon JH; Park S; Park S; Moon KH; Cheon SH; Kwon T
Investig Clin Urol; 2018 Nov; 59(6):376-382. PubMed ID: 30402570
[TBL] [Abstract][Full Text] [Related]
40. Five-year experience with metallic stents for chronic ureteral obstruction.
Kadlec AO; Ellimoottil CS; Greco KA; Turk TM
J Urol; 2013 Sep; 190(3):937-41. PubMed ID: 23485505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
